Download PDF
CC BY-NC-ND 4.0 · International Journal of Epilepsy 2014; 01(02): 069-074
DOI: 10.1016/j.ijep.2014.11.001
Original Article
Thieme Medical and Scientific Publishers Private Ltd.

Status epilepticus in adults: A study from Nigeria

Lukman Femi Owolabi
a   Department of Medicine, Aminu Kano Teaching Hospital, Bayero University, Kano PMB 3452, Nigeria
,
Aliyu Ibrahim
a   Department of Medicine, Aminu Kano Teaching Hospital, Bayero University, Kano PMB 3452, Nigeria
,
Alhassan Datti Mohammed
b   Department of Anesthesiology and Intensive Care, Aminu Kano Teaching Hospital, Bayero University, Kano PMB 3452, Nigeria
,
Shakirah D. Owolabi
c   Department of Psychiatry, Aminu Kano Teaching Hospital, Bayero University, Kano PMB 3452, Nigeria
› Author Affiliations
Further Information

Publication History

Received: 24 May 2014

Accepted: 04 November 2014

Publication Date:
04 May 2018 (online)

   Permissions and Reprints

Abstract

Background Status epilepticus (SE) is a common neurologic emergency. Immediate treatment to stop seizure activity and prompt diagnostic evaluation to recognize potentially treatable causes are paramount in the management of SE. Thus, increased awareness of presentation, etiologies, and treatment of status epilepticus SE is central in the practice of critical care medicine. However, there is a paucity of information on SE from Nigeria.

Objective We evaluated the clinical profile and predictors of one-month outcome in a group of Nigerian patients with SE.

Methodology Patients with SE were recruited from the medical, high dependency unit, intensive care unit and accident and emergency departments of a tertiary hospital from 2008 to 2013. The outcome was assessed using Glasgow Outcome Score (GOS). The outcome, which was categorized into dead (GOS = 1) or alive was analyzed in a multivariate logistic regression model.

Result A total of 76 patients was studied. The four most common underlying etiologies were stroke, antiepileptic drug (AED) non-compliance, CNS infections and metabolic derangement. Fifty-nine (77.6%) patients survived. Duration of seizure, delay in initiation of treatment (Odd ratio (OR) = 4.4, 95% CI = 1.17–16.56), refractory status epilepticus (OR = 87.1, 95% CI = 12.94–781.1) were significantly associated with death. On multivariate analysis, however, refractory status epilepticus remained an independent predictor of death.

Conclusion Our study showed that the most common underlying etiologies in SE were stroke, antiepileptic drug non-compliance CNS infections and metabolic derangement. Duration of seizure, delay in treatment and refractory the SE were significantly associated with death, but refractory seizure was an independent predictor of death in SE.

Keywords

Etiology - Predictor - Outcome - Status epilepticus - Nigeria
 

  • References

  • 1 Lowenstein DH. Status epilepticus: an overview of the clinical problem. Epilepsia 40 1999; 3-8
    PubMedGoogle Scholar
  • 2 Lowenstein DH, Alldredge BK. Status epilepticus at an urban public hospital in the 1980s. Neurology 43 1993; 483-488
    CrossrefPubMedGoogle Scholar
  • 3 Owolabi LF, Shehu MY, Shehu MN, Fadare J. Pattern of neurological admissions in the tropics: experience in Kano, northwestern Nigeria. Ann Indian Acad Neurol 13 2010; 167-170
    CrossrefPubMedGoogle Scholar
  • 4 Ogunniyi A, Ogunniyi JO, Bademosi O, Osuntokun BO, Adeuja AO. Etiology of status epilepticus in Ibadan: a neuropathologic study. West Afr J Med 11 1992; 263-267
    PubMedGoogle Scholar
  • 5 Aminoff MJ, Simon RP. Status epilepticus: causes, clinical features and consequences in 98 patients. Am J Med 69 1980; 657-666
    CrossrefPubMedGoogle Scholar
  • 6 Hauser WA. Status epilepticus: frequency, etiology, and neurological sequelae. Delgado-Escueta AV, Wasterlain CG, Treiman DM, Porter RJ. Advances in Neurology. vol. 34 1983. Raven Press; New York: 3-14 Status Epilepticus
    Google Scholar
  • 7 Cranford RE, Leppik IE, Patrick B, Anderson CB, Kostick B. Intravenous phenytoin in acute treatment of seizures. Neurology 29 1979; 1474-1479
    CrossrefPubMedGoogle Scholar
  • 8 Claassen J, Lokin JK, Fitzsimmons BFM, Mandelssohn FA, Mayer SA. Predictors of functional disability and mortality after status epilepticus. Neurology 58 2002; 139-142
    CrossrefPubMedGoogle Scholar
  • 9 Sagduyu A, Tarlacci S, Sirin H. Generalized tonic-clonic status epilepticus: causes, treatment, complications and predictors of case fatality. J Neurol 245 1998; 640-646
    CrossrefPubMedGoogle Scholar
  • 10 Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 22 1981; 489-501
    CrossrefPubMedGoogle Scholar
  • 11 Hui ACF, Joynt GM, Li H, Wong KS. Status epilepticus in Hong Kong Chinese: etiology, outcome and predictors of death and morbidity. Seizure 12 2003; 478-482
    CrossrefPubMedGoogle Scholar
  • 12 Committee on Protocol for the Management of Medical Emergencies in Aminu Kano Teaching Hospital. Protocol for the Management of Status Epilepticus. vol. 1 2009. Endem Press; 102-105
    Google Scholar
  • 13 Brainin M, Barnes M, Baron JC. et al. Guidance for the preparation of neurological management guidelines by EFNS scientific task forces – revised recommendations 2004. Eur J Neurol 11 2004; 577-581
    CrossrefPubMedGoogle Scholar
  • 14 Claassen J, Hirsch LJ, Mayer SA. Treatment of status epilepticus: a survey of neurologists. J Neurol Sci 211 2003; 37-41
    CrossrefPubMedGoogle Scholar
  • 15 Murthy JMK, Jayalaxmi SS, Kanikannan MA. Convulsive status epilepticus: clinical profile in a developing country. Epilepsia 48 2007; 2217-2223
    PubMedGoogle Scholar
  • 16 Jennett B, Bond M. Assessment of outcome after severe brain damage. A practical scale. Lancet 1 1975; 480-484
    Google Scholar
  • 17 Mhodj I, Nadiaye M, Sene F. et al. Treatment of status epilepticus in a developing country. Neurophysiol Clin 30 2000; 165-169
    CrossrefPubMedGoogle Scholar
  • 18 Towne AR, Pellock JM, Ko D, DeLorenzo RJ. Determinants of mortality in status epilepticus. Epilepsia 35 1994; 27-34
    CrossrefPubMedGoogle Scholar
  • 19 Ozdilek B, Midi I, Agan K, Bingol CA. Episodes of status epilepticus in young adults: etiologic factors, subtypes, and outcomes. Epilepsy Behav 27 2013; 351-354
    CrossrefPubMedGoogle Scholar
  • 20 Tatum WO, French JA, Benbadis SR, Kaplan PW. The etiology and diagnosis of status epilepticus. Epilepsy Behav 2 2001; 311-317
    CrossrefPubMedGoogle Scholar
  • 21 Treiman DM, DeGiorgio CM, Salisbury SM, Wickboldt CL. Subtle generalized convulsive status epilepticus. Epilepsia 25 1984; 653
    PubMedGoogle Scholar
  • 22 Kaplan PW. Nonconvulsive status epilepticus. Sem Neurol 16 1996; 33-40
    Article in Thieme ConnectPubMedGoogle Scholar
  • 23 Treiman DM. Effective treatment for status epilepticus. Schmidt D, Schachter SC. Epilepsy Problem Solving in Clinical Practice. 2000. Martin Dunitz Ltd; United Kingdom: 253-265
    Google Scholar
  • 24 Li JM, Chen L, Zhou B, Zhu Y, Zhou D. Convulsive status epilepticus in adults and adolescents of southwest China: mortality, etiology, and predictors of death. Epilepsy Behav 14 2009; 146-149
    CrossrefPubMedGoogle Scholar
  • 25 Celesia GC, Messert B, Murphy J. Status epilepticus of late adult onset. Neurology 22 1972; 1045-1055
    PubMedGoogle Scholar
  • 26 Owolabi LF, Nagoda M. Stroke in developing countries: experience at Kano, Northwestern Nigeria. Sudan JMS 7 2012; 9-14
    PubMedGoogle Scholar
  • 27 Massaro AR. Stroke in Brazil: a South America perspective. Int J Stroke 1 2006; 113-115
    CrossrefPubMedGoogle Scholar
  • 28 Owolabi LF, Akinyemi RO, Owolabi MO, Sani MU, Ogunniyi A. Profile of stroke-related late onset epilepsy among Nigerians. J Med Trop 15 2013; 29-32
    PubMedGoogle Scholar
  • 29 Jones JE, Hermann BP, Barry JJ, Gilliam FG, Kanner AM, Meador KJ. Rates and risk factors for suicide, suicidal ideation, and suicide attempts in chronic epilepsy. Epilepsy Behav 4 2003; S31-S38
    CrossrefPubMedGoogle Scholar
  • 30 Faught E, Duh MS, Weiner JR, Gu'erin A, Cunnington MC. Non-adherence to anti-epileptic drugs and increased mortality: findings from the RANSOM study. Neurology 70 2008; 1572-1578
    PubMedGoogle Scholar
  • 31 DeLorenzo RJ, Hauser WA, Towne AR. et al. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 46 1996; 1029-1035
    CrossrefPubMedGoogle Scholar
  • 32 Owolabi LF. Precipitants of seizure among patients with epilepsy: experience at Kano, Northwestern Nigeria. Sahel Med J 15 2012; 24-29
    PubMedGoogle Scholar
  • 33 Garzon E, Fernandes RM, Sakamoto AC. Analysis of clinical characteristic and risk factors for mortality in human status epilepticus. Seizure 12 2003; 237-245
    CrossrefPubMedGoogle Scholar
  • 34 Maharaj M, Henry D, Alik K, Mohammed PD. Status epilepticus: recent experience at the Port-of-Spain General Hospital, Trinidad. West Indian Med J 41 1992; 19-22
    PubMedGoogle Scholar
  • 35 Kwong KL, Lee SL, Yung A, Wong VC. Status epilepticus in 37 Chinese children: etiology and outcome. J Paediatr Child Health 31 1995; 395-398
    CrossrefPubMedGoogle Scholar
  • 36 Koubeissi M, Alshekhlee A. In-hospital mortality of generalized convulsive status epilepticus: a large US sample. Neurology 69 2007; 886-893
    CrossrefPubMedGoogle Scholar
  • 37 Legriel S, Mourvillier B, Bele N. et al. Outcomes in 140 critically ill patients with status epilepticus. Intensive Care Med 34 2008; 476-480
    CrossrefPubMedGoogle Scholar
  • 38 Hesdorfer DC, Logroscino G, Cascino G, Annegars JF, Hauser WA. Incidence of status epilepticus in Rochester, Minnesota, 1965–1986. Neurology 50 1998; 735-741
    CrossrefPubMedGoogle Scholar
  • 39 Waterhouse EJ, Garnett LK, Towne AR. et al. Prospective population-based study of intermittent and continuous convulsive status epilepticus in Richmond, Virginia. Epilepsia 40 1999; 752-758
    CrossrefPubMedGoogle Scholar
  • 40 Coeytaux A, Jallon P, Galobardes B. et al. Incidence of status epilepticus in French speaking Switzerland (EPISTAR). Neurology 50 1998; 735-741
    CrossrefPubMedGoogle Scholar
  • 41 Owolabi LF, Mohammed AD, Dalhat MM, Ibrahim A, Aliyu S, Owolabi DS. Factors associated with death and predictors of 1-month mortality in nontraumatic coma in a tertiary hospital in Northwestern Nigeria. Indian J Crit Care Med 17 2013; 219-223
    CrossrefPubMedGoogle Scholar